SAFETY AND TOLERABILITY CHARACTERIZATION OF MARALIXIBAT IN INFANTS WITH ALGS FROM 2 MONTHS OF AGE: INTERIM RESULTS FROM THE RISE STUDY

被引：0
|
作者：
Gonzales, Emmanuel [1 ,2 ]
Jankowska, Irena [3 ]
Horslen, Simon P. [4 ]
Ekong, Udeme [5 ]
Rosenthal, Philip [6 ]
Sokal, Etienne [7 ]
Lin, Chuan-Hao [8 ]
Garner, Will [9 ]
Elliott, Jilliann [9 ]
Nunes, Tiago [9 ]
Thompson, Richard J. [10 ]
机构：
[1] Univ Paris Saclay, Inserm Umr 1193, Hepatinov, Orsay, France
[2] Univ Paris Saclay, Hop Bicetre, AP HP, Ctr Reference Natl Atresie Voies Biliaires & Chol, Le Kremlin Bicetre, France
[3] Childrens Mem Hlth Inst, Gastroenterol Hepatol Nutr Disorders & Paediat, Warsaw, Poland
[4] UPMC Childrens Hosp Pittsburgh, Pediat, Pittsburgh, PA USA
[5] Medstar Georgetown Univ Hosp, Medstar Georgetown Transplant Inst, Washington, DC USA
[6] Univ Calif San Francisco, Div Pediat Gastroenterol Hepatol & Nutr, Pediat, San Francisco, CA USA
[7] Clin Univ St Luc, Uclouvian, Pediat Hepatol, Brussels, Belgium
[8] Childrens Hosp Angeles, Los Angeles, CA USA
[9] Mirum Pharmaceut Inc, Foster City, CA USA
[10] Kings Coll London, Inst Liver Studies, London, England
来源：
HEPATOLOGY | 2023年 / 77卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5021
引用
收藏
页码：E135 / E135
页数：1
相关论文
共 50 条
  • [11] SAFETY, TOLERABILITY, AND OUTCOMES OF SOFOSBUVIR/VELPATASVIR IN TREATMENT OF CHRONIC HEPATITIS C VIRUS DURING PREGNANCY: INTERIM RESULTS FROM THE STORC STUDY
    Chappell, Catherine
    Charles, Jasmin
    Smid, Marcela
    Rood, Kara
    Cafardi, John
    Kushner, Tatyana
    Biondi, Mia
    Feld, Jordan
    Yudin, Mark
    Eastabrook, Genevieve
    Osmundson, Sarah
    Davies, Todd
    Leslie, Meyn
    Letterio, Cathleen
    Kwon, Kyung Min
    Kreter, Bruce
    Hillier, Sharon
    HEPATOLOGY, 2024, 80 : S746 - S747
  • [12] SAFETY, TOLERABILITY, AND OUTCOMES OF SOFOSBUVIR/VELPATASVIR IN TREATMENT OF CHRONIC HEPATITIS C VIRUS DURING PREGNANCY: INTERIM RESULTS FROM THE STORC STUDY
    Chappell, Catherine Anne
    HEPATOLOGY, 2024, 79 (02) : E51 - E52
  • [13] Lean Tissue Deficit in Preterm Infants Persists up to 4 Months of Age: Results from a Swedish Longitudinal Study
    Chmielewska, Anna
    Farooqi, Aijaz
    Domellof, Magnus
    Ohlund, Inger
    NEONATOLOGY, 2020, 117 (01) : 80 - 87
  • [14] THE EFFICACY, SAFETY, AND TOLERABILITY OF PROBIOTICS ON SYMPTOMS OF DEPRESSION: RESULTS FROM A PILOT STUDY
    Wallace, C.
    Foster, J.
    Milev, R.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 55 - 55
  • [15] The safety and tolerability of natalizumab: Results from the safety-extension study in patients with multiple sclerosis
    O'Connor, PW
    Goodman, A
    Kappos, L
    Lublin, FD
    Miller, DH
    Polman, CH
    Rudick, RA
    Lynn, F
    Panzara, MA
    Sandrock, AW
    NEUROLOGY, 2006, 66 (05) : A34 - A34
  • [16] SAFETY AND TOLERABILITY OF ATORVASTATIN CALCIUM ANHYDROUS IN KOREAN PATIENTS WITH DYSLIPIDEMIA: AN INTERIM ANALYSIS FROM THE LAMP STUDY
    Hong, Soon Jun
    Choi, So-Yeon
    Han, Seung Hwan
    Choi, Young Jin
    Ahn, Taehoon
    ATHEROSCLEROSIS, 2017, 263 : E236 - E236
  • [17] A LONGITUDINAL-STUDY OF PRISM ADAPTATION IN INFANTS FROM 6 TO 9 MONTHS OF AGE
    MCDONNELL, PM
    ABRAHAM, WC
    CHILD DEVELOPMENT, 1981, 52 (02) : 463 - 469
  • [18] The longitudinal study of gaze following ability in infants from 10 to 14 months of age
    Kotyusov, Alexander I.
    Kunnikova, Ksenia I.
    Valieva, Elmira R.
    Malykh, Sergey B.
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2023, 58 : 972 - 972
  • [19] Safety of TTFields and radiotherapy (RT) for newly diagnosed glioblastoma: Interim safety results from a pilot study
    Grossman, Rachel
    Ram, Zvi
    CANCER RESEARCH, 2018, 78 (13)
  • [20] Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Efficacy and Safety Results From the Phase 2 NURTURE Study
    Crawford, T.
    De Vivo, D.
    Bertini, E.
    Hwu, W. L.
    Foster, R.
    Bhan, I
    Farwell, W.
    Reyna, S.
    ANNALS OF NEUROLOGY, 2018, 84 : S392 - S392
12345